REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TechMARK movers: Vodafone goes ex-dividend

Wed, 17th Nov 2010 13:38

TechMARK's decline will undoubtedly have been influenced by Vodafone going ex-dividend. Mobile phone networks operator Vodafone is paying an interim dividend of 2.85p a share, which is similar to the size of the fall in the share price. Vodafone is the biggest company in TechMARKPositive news from the second biggest company in TechMARK, GlaxoSmithKline, which is around three-quarters of Vodafone's size, will have helped to offset the ex-dividend effect.Panmure Gordon has upgraded its forecasts for GlaxoSmithKline following the endorsement of potential Lupus drug Benlysta by an FDA advisory committee by a margin of 13-2. The broker has upgraded 2013 earnings by 1.6% and 2014 earnings by 1.5%.Chip designer Imagination Technologies is building up its war chest with a £37.8m share placing at 310p a share. The share price has dipped below the placing price.The cash will be used to fund acquisitions. The first is HelloSoft, a US voice over internet protocol (VOIP) operator. Imagination is paying a maximum of $47m for Hellosoft, a company that has technology patents that are complementary to Imagination's. The initial payment is $20.2m (£12.7m). The final consideration is dependent on the performance of Hellosoft over the next three years.Interim figures will be published on 14 December. Biotech Phytopharm has jumped on the back of the commencement of a phase II study into its Parkinson's disease treatment Cogane. The results of the study should be available by end of 2012.FTSE TechMARK - RisersPhytopharm (PYM) 7.93p +11.22%Ark Therapeutics Group (AKT) 4.30p +4.88%E2V Technologies (E2V) 88.50p +2.31%Oxford Biomedica (OXB) 9.80p +1.14%AEA Technology Group (AAT) 5.25p +0.96%Xaar (XAR) 216.00p +0.93%Emblaze Ltd. (BLZ) 47.00p +0.53%Kewill (KWL) 93.25p +0.27%FTSE TechMARK - FallersAsterand (ATD) 10.25p -12.77%Imagination Technologies Group (IMG) 309.00p -4.92%Cable & Wireless Worldwide (CW.) 66.55p -3.41%Renovo Group (RNVO) 33.50p -2.90%Sepura (SEPU) 42.00p -2.89%Promethean World (PRW) 77.75p -2.51%Puricore (PURI) 50.50p -2.42%Vodafone Group (VOD) 167.00p -2.02%KCOM Group (KCOM) 49.00p -2.00%Cobham (COB) 201.20p -1.61%
More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.